Long-term Evaluation of the Efficacy and Safety of Splentis for the Treatment of Primary Apical Pelvic Organ Prolapse
Condition(s):Pelvic Organ ProlapseLast Updated:December 29, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Pelvic Organ ProlapseLast Updated:December 29, 2022Recruiting
Condition(s):Uterine Prolapse; Cystocele; Rectocele; EnteroceleLast Updated:September 11, 2006Unknown status
Condition(s):Vaginal Vault Prolapse; Pelvic Organ Prolapse; Uterine Prolapse; Pelvic Floor ProlapseLast Updated:August 20, 2020Completed
Condition(s):Stress Urinary Incontinence; Pelvic Organ ProlapseLast Updated:March 27, 2024Recruiting
Condition(s):Pelvic Organ ProlapseLast Updated:October 13, 2014Completed
Condition(s):Sacral Colpopexy; Pelvic Organ ProlapseLast Updated:June 9, 2017Completed
Condition(s):Vaginal Prolapse; Uterine Prolapse; Cystocele; Pelvic Organ ProlapseLast Updated:October 30, 2020Completed
Condition(s):Prolapse of the UterusLast Updated:April 13, 2020Completed
Condition(s):Uterovaginal Prolapse; HysteropexyLast Updated:August 25, 2016Unknown status
Condition(s):Rectocele; Female; Rectocele and Incomplete Uterine Prolapse; Rectocele and Complete Uterovaginal Prolapse; Rectal ProlapseLast Updated:April 19, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.